233 related articles for article (PubMed ID: 11513374)
21. Subcortical overactivation in untreated schizophrenic patients: a functional magnetic resonance image finger-tapping study.
Müller JL; Röder C; Schuierer G; Klein HE
Psychiatry Clin Neurosci; 2002 Feb; 56(1):77-84. PubMed ID: 11929574
[TBL] [Abstract][Full Text] [Related]
22. Cognitive effects of olanzapine and clozapine treatment in chronic schizophrenia.
Sharma T; Hughes C; Soni W; Kumari V
Psychopharmacology (Berl); 2003 Sep; 169(3-4):398-403. PubMed ID: 12845415
[TBL] [Abstract][Full Text] [Related]
23. "Normalization" of brain activation in schizophrenia. An fMRI study.
Lund A; Kroken R; Thomsen T; Hugdahl K; Smievoll AI; Barndon R; Iversen J; Landrø NI; Sundet K; Rund BR; Ersland L; Lundervold A; Asbjørnsen A
Schizophr Res; 2002 Dec; 58(2-3):333-5. PubMed ID: 12409175
[No Abstract] [Full Text] [Related]
24. Olanzapine modulates the default-mode network homogeneity in recurrent drug-free schizophrenia at rest.
Guo W; Liu F; Chen J; Wu R; Li L; Zhang Z; Chen H; Zhao J
Aust N Z J Psychiatry; 2017 Oct; 51(10):1000-1009. PubMed ID: 28605934
[TBL] [Abstract][Full Text] [Related]
25. An MRI study of cerebellar vermis morphology in patients with schizophrenia: evidence in support of the cognitive dysmetria concept.
Nopoulos PC; Ceilley JW; Gailis EA; Andreasen NC
Biol Psychiatry; 1999 Sep; 46(5):703-11. PubMed ID: 10472423
[TBL] [Abstract][Full Text] [Related]
26. Functional lateralization of the sensorimotor cortex in patients with schizophrenia: effects of treatment with olanzapine.
Bertolino A; Blasi G; Caforio G; Latorre V; De Candia M; Rubino V; Callicott JH; Mattay VS; Bellomo A; Scarabino T; Weinberger DR; Nardini M
Biol Psychiatry; 2004 Aug; 56(3):190-7. PubMed ID: 15271588
[TBL] [Abstract][Full Text] [Related]
27. Mapping Thalamocortical Functional Connectivity in Chronic and Early Stages of Psychotic Disorders.
Woodward ND; Heckers S
Biol Psychiatry; 2016 Jun; 79(12):1016-25. PubMed ID: 26248537
[TBL] [Abstract][Full Text] [Related]
28. Altered effective connectivity during working memory performance in schizophrenia: a study with fMRI and structural equation modeling.
Schlösser R; Gesierich T; Kaufmann B; Vucurevic G; Hunsche S; Gawehn J; Stoeter P
Neuroimage; 2003 Jul; 19(3):751-63. PubMed ID: 12880804
[TBL] [Abstract][Full Text] [Related]
29. Olanzapine: keep an eye on this neuroleptic.
Leblanc G
Can Fam Physician; 2000 Aug; 46():1565-6, 1569. PubMed ID: 10955171
[No Abstract] [Full Text] [Related]
30. [Effect of olanzapine treatment on cognitive functions in patients with schizophrenia].
Radziwiłłowicz P; Radziwiłłowicz W; Lis J
Psychiatr Pol; 2002; 36(6):967-87. PubMed ID: 12725025
[TBL] [Abstract][Full Text] [Related]
31. Olanzapine effects on auditory sensory gating in schizophrenia.
Arango C; Summerfelt A; Buchanan RW
Am J Psychiatry; 2003 Nov; 160(11):2066-8. PubMed ID: 14594761
[TBL] [Abstract][Full Text] [Related]
32. Disruptive changes of cerebellar functional connectivity with the default mode network in schizophrenia.
Wang L; Zou F; Shao Y; Ye E; Jin X; Tan S; Hu D; Yang Z
Schizophr Res; 2014 Dec; 160(1-3):67-72. PubMed ID: 25445623
[TBL] [Abstract][Full Text] [Related]
33. Comparative effects of risperidone and olanzapine on cognition in elderly patients with schizophrenia or schizoaffective disorder.
Harvey PD; Napolitano JA; Mao L; Gharabawi G
Int J Geriatr Psychiatry; 2003 Sep; 18(9):820-9. PubMed ID: 12949850
[TBL] [Abstract][Full Text] [Related]
34. Impaired Effective Connectivity During a Cerebellar-Mediated Sensorimotor Synchronization Task in Schizophrenia.
Moussa-Tooks AB; Kim DJ; Bartolomeo LA; Purcell JR; Bolbecker AR; Newman SD; O'Donnell BF; Hetrick WP
Schizophr Bull; 2019 Apr; 45(3):531-541. PubMed ID: 29800417
[TBL] [Abstract][Full Text] [Related]
35. Converging evidence for the association of functional genetic variation in the serotonin receptor 2a gene with prefrontal function and olanzapine treatment.
Blasi G; De Virgilio C; Papazacharias A; Taurisano P; Gelao B; Fazio L; Ursini G; Sinibaldi L; Andriola I; Masellis R; Romano R; Rampino A; Di Giorgio A; Lo Bianco L; Caforio G; Piva F; Popolizio T; Bellantuono C; Todarello O; Kleinman JE; Gadaleta G; Weinberger DR; Bertolino A
JAMA Psychiatry; 2013 Sep; 70(9):921-30. PubMed ID: 23842608
[TBL] [Abstract][Full Text] [Related]
36. Olanzapine.
Hale AS
Br J Hosp Med; 1997 Nov 5-18; 58(9):442-5. PubMed ID: 9619205
[TBL] [Abstract][Full Text] [Related]
37. Effects of olanzapine and clozapine upon pulse rate variability.
Mueck-Weymann M; Rechlin T; Ehrengut F; Rauh R; Acker J; Dittmann RW; Czekalla J; Joraschky P; Musselman D
Depress Anxiety; 2002; 16(3):93-9. PubMed ID: 12415532
[TBL] [Abstract][Full Text] [Related]
38. Switching schizophrenia patients from typical neuroleptics to olanzapine: effects on BOLD response during attention and working memory.
Schlagenhauf F; Wüstenberg T; Schmack K; Dinges M; Wrase J; Koslowski M; Kienast T; Bauer M; Gallinat J; Juckel G; Heinz A
Eur Neuropsychopharmacol; 2008 Aug; 18(8):589-99. PubMed ID: 18554874
[TBL] [Abstract][Full Text] [Related]
39. Effects of olanzapine on auditory P300 in schizophrenia.
Gonul AS; Suer C; Coburn K; Ozesmi C; Oguz A; Yilmaz A
Prog Neuropsychopharmacol Biol Psychiatry; 2003 Feb; 27(1):173-7. PubMed ID: 12551741
[TBL] [Abstract][Full Text] [Related]
40. Negative symptoms: a path analytic approach to a double-blind, placebo- and haloperidol-controlled clinical trial with olanzapine.
Tollefson GD; Sanger TM
Am J Psychiatry; 1997 Apr; 154(4):466-74. PubMed ID: 9090332
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
